received lecture fees from Sanofi, AstraZeneca and Janssen and has served as a consultant for AbbVie, Sanofi, Novo Nordisk, AstraZeneca, Boehringer Ingelheim and Merck Sharp & Dohme
The short answer for subcutaneous GLP-1 injections is that small air bubbles pose virtually no health risk
Because they operate more like manufacturers, 503B facilities must register with the FDA and follow stringent Current Good Manufacturing Practices (cGMP) requirements, which are the same standards drug manufacturers must meet
Insurance coverage, HSA/FSA eligibility, and reimbursability, if any, depend on the buyer's specific plan and are not confirmed by this article
Choices should be made against daily realities , not just marketing